Find Articles in:
All
Business
Reference
Technology
News
Lifestyle

LATANOPROST.(drug for glaucoma)(Brief Article)

Chemical Market Reporter, June, 2000

Content provided in partnership with HighBeam Research

FDA has issued an approvable letter for Pharmacia Corporation's investigational drug Xalcom, a fixed combination of Xalatan (latanoprost ophthalmic solution) and timolol (beta blocker). Pharmacia is seeking an indication for Xalcom to reduce intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

 

BNET TalkbackShare your ideas and expertise on this topic

The following tags are supported in BNET comments:
<b></b> <i></i> <u></u> <pre></pre>

Leave a Reply

  1. You are currently a guest | Login?
advertisement
Go
advertisement
  • Click Here
  • Click Here
advertisement